Arrowstreet Capital
KURA icon

Arrowstreet Capital’s Kura Oncology KURA Stock Holding History

Arrowstreet Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-49,913
Closed -$1.63M – 2385
2020
Q4 		$1.63M Buy
+49,913
New +$1.75M ﹤0.01% 1673
2020
Q3 		– Sell
-55,186
Closed -$900K – 2423
2020
Q2 		$900K Buy
+55,186
New +$796K ﹤0.01% 1809

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital's KURA Position: Q1 2021 in Review

Arrowstreet Capital sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 49,913 shares — an estimated $1.63M sold.

Arrowstreet Capital first reported a position in KURA in Q2 2020 and held it in 2 quarters. The position peaked at $1.63M in Q4 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

  • Arrowstreet Capital reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 49,913 Kura Oncology shares in Q1 2021, an estimated $1.63M.
  • Arrowstreet Capital first reported a position in Kura Oncology in Q2 2020 and held it in 2 quarters.
  • Arrowstreet Capital's Kura Oncology position peaked at $1.63M in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.